Dental care to patients using Biposphonates: Case report
Keywords:Osteoporosis; Diphosphonates; Osteonecrosis; Dentists.
Osteoporosis is a progressive systemic disease of the skeleton, characterized by reduced bone density and microstructure deterioration of bone tissue. For treatment, the use of bisphosphonates (BFFs) has been recommended as the first choice anti-resorptive therapy. The objective of this work is to describe, through a case report, a dental care protocol for a patient with Osteoporosis and using BFs. The work was submitted and approved by the Research Ethics Committee (CEP), opinion No.: 3.646.508/2019. Female patient, 30 years old, black, with osteoporosis, was referred for dental treatment. At the time of the Anamnesis, he reported using Alendronate Sodium 70mg/day. After clinical examination, laboratory tests for CTX-I dosage and radiographic evaluation, the suggested treatment plan was presented: clinical crown augmentation surgery and subsequent endodontic treatment and oral rehabilitation of tooth 25, which was promptly approved by the patient and signed the Informed Consent Term (TCLE). One week before the surgical procedure for clinical crown augmentation, the suspension of Alendronate sodium was requested. After the endodontic treatment, the prosthetic rehabilitation was carried out, restoring the masticatory and aesthetic function of the teeth, restoring the patient's self-esteem. It was concluded in the present study that it is possible to carry out the dental treatment of patients in bisphosphonate therapy safely, if a well-conducted and detailed anamnesis is carried out and safe treatment protocols are adopted, always aiming at the quality of life and patient satisfaction.
AlRahabi, M. K., & Ghabbani, H. M. (2018). Saudi Medical Journal, 39 (3): 232-238.
Bell, B. M., & Bell, R. E. (2008). Bifosfonatos orais e implantes dentários: um estudo retrospectivo. Journal Of Oral And Maxillo Facial Surgery, 5(66): 4-10.
Coléte, J.Z., Hadad, H., Momesso, G. A. C., Santos Filho, H., Breno dos Reis, F., & Garcia Júnior, I. R. (2019). Implantes em pacientes com osteonecrose dos maxilares associado ao uso de bifosfonatos: relato de caso e revisão de literatura. Archives of Health Investigation, 8(1):20-27.
Cremers, S., Drake, M. T., Ebetino, F. H., Bilezikian, J. P., & Russell, R. (2019). Pharmacology of isphosphonates. British journal of clinical pharmacology, 85(6):1052-1062.
Estrela, C. Metodologia científica: ciência, ensino, pesquisa. (3a ed.), Artes Médicas, 2018.
Granate-Marques, A., Polis-Yanes, C., Seminario-Amez, M., Jané-Salas, E., & López-López, J. (2019). Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review. Medicina Oral, Patologia Oral, Cirugia Bucal, 24(2):e195-e203.
Hillner, B. E., et al (2000). American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. Journal of Clinical Oncology, 18(6):1378-91.
Hsiao, A., Glickman, G., & He, J. (2009). A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. Journal of Endodontics, 35(11):1525-8.
Marx, R. E., Cillo, J. E., & Ulloa, J. J. (2007). Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment. Journal of oral and Maxillofacial Surg, 65(12):2397-2410.
Medeiros, I. L., Rebouças, S. C. R., Souza Junior, F. A., Araújo Neto, G. H., Pinheiro, S. S., & Barroso, M. L. F. (2020). Implantes dentários e a osteonecrose dos maxilares associado ao bifosfonato: uma revisão integrativa. Research, Society and Development, 9(10): e6519108622.
Mendes, V., et al (2019). Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence. International Journal of Oral and Maxillofacial Surgery, 48(3):373-381.
Migliorati, C. A., et al (2005a). Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer;104(1):83-93.
Migliorati, C. A., et al (2005b). Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. Journal of American Dental Association, 136(12):1658-68.
Nicolatou-Galitis, O., Schiødt, M., Mendes, R. A., Ripamonti, C., Hope, S., Drudge-Coates, L., Niepel, D., & Van den Wyngaert, T. (2019). Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surgery Oral Medical Oral Pathology Oral Radiology, 127(2):117-135.
Osborne, P. R., Mendes, B., Faverani, L. P., Alexandre, C. N., & Jesus, G. P. (2020). Osteonecrose Maxilar Induzida por medicamento anti-reabsortivo (Bisfosfonato) em Paciente Portador de Mieloma Múltiplo – Relato de caso. Research, Society and Development, 9(11): e1179119415.
Paiva, C. L.O. C., Silva, N. M. M., Oliveira, T. A., Souza, J. A. N., Pereira, G. M.A., & Souza Júnior, F.A. (2021). Osteonecrose dos maxilares relacionada ao uso de medicamentos: Revisão sistemática. Research, Society and Development, 10(5): e15510514740.
Pereira, M. G. Epidemiologia: teoria e prática. Guanabara Koogan, 1995.
Pinto Junior, A. A. C., et al (2017). Osteonecrose dos Maxilares Associada ao uso de Bisfosfonatos. Rev. Cir. Traumatol. Buco-Maxilo-Fac., 17(1): 40-45.
Ribeiro, G. H., et al (2018). Osteonecrose da mandíbula: revisão e atualização em etiologia e tratamento. Brazilian Journal of Otorhinolaryngology. 84 (1) 102-108.
Ruggiero, S. L., et al. Task Force on American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J. 2009;35(3):119-30.
Santos, L. C. S., et al (2016). Influência Do Uso De Bisfosfonatos em Pacientes Submetidos a Implantes Dentários - Revisão da Literatura. Revista Bahiana de Odontologia, 7(1):22-30.
Silva, S. E. (2016). Uso do exame laboratorial CTX na avaliação de prognóstico cirúrgico odontológico em pacientes com histórico de uso de bisfosfonato. Porto velho: Universidade São Lucas.
Song, M. (2019). Dental care for patients taking antiresorptive drugs. A literature review. Restorative Dentistry and Endodontics, 44(4):e42-58.
Vilela-Carvalho, L. N., et al (2018). Osteonecrose dos maxilares relacionada ao uso de medicações: Diagnóstico, tratamento e prevenção. CES Odontologia, 31(2) :48-63
Zanata, A., Felin, G. C., De Bona, M. C., Sawazaki, R., & De Conto, F. (2014). Osteonecrose mandibular associada ao uso de bisfosfonato de sódio em paciente com mieloma múltiplo. Revista Portuguesa de Estomatologia e Medicina Dentaria e Cirurgi Maxilofacial, 55(2):115-20.
How to Cite
Copyright (c) 2021 Elizama de Lima Amazonas; Darcleia Souza Sacht; Ranniely de Souza Alves; Nely Cristina Medeiros Caires
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.